Coronary Artery Bypass Graft Market Report Scope & Overview:

The Coronary Artery Bypass Graft Market size is valued at USD 19.56 Billion in 2025 and is projected to reach USD 26.79 Billion by 2035, growing at a CAGR of 3.22% during the forecast period 2025–2035.

The Coronary Artery Bypass Graft Market study sheds light on the development of surgical revascularization techniques, graft technology, and sophisticated cardiac equipment. It highlights market drivers such as the increased incidence of coronary heart disease, aging populations, and the demand for efficient treatment options in hospital environments from 2026 to 2035.

CABG procedures surpassed 1.6 million in 2025, driven by rising coronary artery disease and aging population.

Market Size and Forecast:

• Market Size in 2025: USD 19.56 Billion

• Market Size by 2035: USD 26.79 Billion

• CAGR: 3.22% from 2026 to 2035

• Base Year: 2025

• Forecast Period: 2026–2035

• Historical Data: 2022–2024

Coronary Artery Bypass Graft Market Trends:

• Rising prevalence of coronary artery disease, diabetes, and hypertension is significantly increasing demand for CABG procedures.

• Growing geriatric population is driving higher incidence of multi-vessel coronary blockages requiring surgical revascularization.

• Advancements in minimally invasive CABG, robotic-assisted surgery, and beating-heart techniques are improving patient outcomes and reducing recovery time.

• Increasing preference for off-pump CABG is reducing complications associated with cardiopulmonary bypass and improving procedural safety.

• Expansion of cardiac specialty hospitals and hybrid operating rooms is enhancing access to advanced bypass surgeries.

• Continuous innovation in graft materials, including arterial grafts with higher patency rates, is improving long-term surgical success.

• Rising adoption of endoscopic vessel harvesting systems and advanced surgical devices is increasing procedural efficiency and precision.

• Growing healthcare expenditure and improved cardiac care infrastructure in emerging economies are expanding market penetration.

U.S. Coronary Artery Bypass Graft Market Insights:

The U.S. Coronary Artery Bypass Graft Market is projected to grow from USD 6.40 Billion in 2025 to USD 8.27 Billion by 2035, at a CAGR of 2.62%. The market is primarily driven by the increase in the prevalence of coronary artery diseases, an aging population, established cardiac care facilities, and the growing adoption of minimally invasive surgeries.

Coronary Artery Bypass Graft Market Growth Drivers:

• Rising coronary artery disease burden and aging population driving sustained demand for CABG procedures.

The major driver behind the growth of the market for Coronary Artery Bypass Graft is an increase in cases of coronary artery disease along with aging people across the world. With a rise in cases of diabetes, hypertension, obesity, and leading an inactive life, the number of multi-vessel obstruction of coronary arteries has increased. In the cases where medication and minimal surgery fail to bring improvement, CABG continues to be a popular choice for surgery.

Over 65% of CABG procedures in 2025 were performed on patients aged above 60, driven by rising geriatric cardiovascular burden.

Coronary Artery Bypass Graft Market Restraints:

• High surgical cost and preference for PCI limiting CABG adoption in some patient populations and regions.

One of the significant limitations that affect the market for Coronary Artery Bypass Grafting is the increasing demand for less-invasive procedures such as PCI and drug-coated stents, which offer shorter stays in hospitals and faster recovery periods. Additionally, CABG operations are more expensive and have higher risks of complications when compared to PCI; hence, their adoption is low. For instance, CABG is relatively expensive since patients must remain in the hospital for longer periods.

Coronary Artery Bypass Graft Market Opportunities:

• Advancements in minimally invasive and robotic-assisted CABG creating strong opportunities for precision cardiac surgery expansion.

One of the opportunities in the Coronary Artery Bypass Graft Market is attributed to the fast development of minimally invasive surgery, robotic surgery, and off-pump surgery. These developments have helped minimize surgical trauma, improve precision, and reduce recovery periods, thus making CABG more effective than other medical options. The investment in infrastructure facilities for cardiac surgery in developing countries will increase the availability of surgical devices. Also, better materials used in grafts have resulted in an increased patency period of CABG procedures.

Minimally invasive and off-pump CABG techniques accounted for nearly 30% of total procedures in 2025, supported by advancing surgical technologies.

Coronary Artery Bypass Graft Market Segmentation Analysis:

• By Procedure / Technology Type, On-Pump CABG (Conventional) held the largest market share of 52.41% in 2025, while Robotic-Assisted CABG is expected to grow at the fastest CAGR of 6.92% during 2026–2035.

• By Graft Type (Conduit Type), Saphenous Vein Grafts (SVG) dominated with a 46.68% market share in 2025, whereas Radial Artery Grafts are projected to register the fastest CAGR of 4.19% through 2026–2035.

• By Device / Product Type, Cardiopulmonary Bypass Machines captured the largest share of 31.57% in 2025, while Endoscopic Vessel Harvesting Systems are anticipated to expand at the fastest CAGR of 4.66% during the forecast period.

• By End User, Hospitals accounted for the highest market share of 68.82% in 2025, while Ambulatory Surgical Centers (ASCs) are expected to grow at the fastest CAGR of 4.73% through 2026–2035.

By Procedure / Technology Type, On-Pump CABG Dominates While Robotic-Assisted CABG is Fastest Growing:

On-Pump CABG segment dominated the market due to the procedural dependability associated with it along with the standardization and universal application of the surgical procedure. This surgery becomes very useful when dealing with complicated multi-vessel cases of CAD that require stable surgical environment. On-Pump CABG procedures in 2025 exceeded 830,000 procedures.

Robotic-assisted CABG is the fastest-growing segment, driven by increasing demand for minimally invasive surgeries that require more accuracy and heal faster owing to developments in robotics in surgery.

By Graft Type, Saphenous Vein Grafts Dominate While Radial Artery Grafts are Fastest Growing:

Saphenous Vein Grafts segment dominated the market due to their availability, versatility, and extensive track record in CABG surgeries. Saphenous vein grafts are preferred for multiple grafting since they offer greater convenience. In 2025, there were more than 720,000 CABG procedures performed using saphenous vein grafts.

Radial artery grafts are the fastest-growing segment, owing to their higher rate of long-term patency, clinical benefits, greater favorability toward arterial grafting methods among modern cardiologists, and improved surgeon expertise.

By Device / Product Type, Cardiopulmonary Bypass Machines Dominate While Endoscopic Vessel Harvesting Systems are Fastest Growing:

Cardiopulmonary Bypass Machines segment dominated the market due to their critical role in performing conventional on-pump CABG surgeries through continuous blood flow and oxygenation during surgery. The critical requirement of cardiopulmonary bypass machines in intricate heart operations ensures that there is consistent demand. Over 610,000 CABG surgeries utilized cardiopulmonary bypass in 2025.

Endoscopic vessel harvesting systems are the fastest-growing segment, due to rising preferences for minimally invasive procedures that cause less trauma to the patient, offer better recovery results, and are more efficient.

By End User, Hospitals Dominate While Ambulatory Surgical Centers are Fastest Growing:

Hospitals segment dominated the market due to the availability of high-end surgical facilities, specialist heart surgeons, and intensive care units that are required to perform complicated bypass surgery. The majority of coronary artery bypass grafting surgeries are conducted at major tertiary hospitals, where more than 1.1 million surgeries were performed in hospitals in 2025.

Ambulatory Surgical Centers are the fastest-growing segment, driven by the need for greater cost-effectiveness, reduced length of stay at hospitals, and a trend toward minimally invasive heart surgeries, owing to the improvements in outpatient cardiac services and medical technology.

Coronary Artery Bypass Graft Market Regional Analysis:

North America Coronary Artery Bypass Graft Market Insights:

The North America Coronary Artery Bypass Graft Market is dominant, holding a 38.64% share in 2025, due to the fact that there is a well-developed healthcare infrastructure for treating heart diseases, large numbers of patients undergoing surgeries, and qualified professionals skilled in performing cardiac operations. The adoption of modern procedures of CABG surgery, high levels of expenditures on healthcare, increased numbers of people suffering from coronary artery disease, and elderly patients make up additional factors favoring North America.

U.S. Coronary Artery Bypass Graft Market Insights:

The U.S. Coronary Artery Bypass Graft Market is due to its sophisticated infrastructure for cardiac surgery, high volume, and expertise in cardiothoracic surgeons. Extensive use of minimally invasive and robotic surgery, coupled with the increasing prevalence of heart diseases and existence of leading hospitals and medical equipment manufacturing organizations, makes the U.S. market for CABG the most advanced in North America.

Asia-Pacific Coronary Artery Bypass Graft Market Insights:

The Asia Pacific Coronary Artery Bypass Graft Market is witnessing rapid expansion with an expected CAGR of 4.79% between 2026 and 2035. Some of the factors driving the expansion in this market include the increased prevalence of coronary artery disease, increase in geriatric populations, and enhanced health care infrastructure in nations such as China, India, and Japan. Other contributing factors include better availability of cardiac surgeries, reduced cost of treatments, and higher instances of medical tourism.

China Coronary Artery Bypass Graft Market Insights:

The China Coronary Artery Bypass Graft Market is driven by increasing incidences of heart-related ailments, an aging population base, and greater accessibility to state-of-the-art cardiac surgery. Investments by the government in medical facilities, an increased number of specialized cardiac hospitals, and more sophisticated methods of surgeries have become key factors behind the market’s growth and China’s dominance in the Asia-Pacific region.

Europe Coronary Artery Bypass Graft Market Insights:

Europe’s Coronary Artery Bypass Grafting market is buoyed by well-developed health systems, highly regarded centers for cardiac surgery, and qualified surgeons in countries such as Germany, the UK, and France. An increasing prevalence of cardiovascular conditions and aging population are significant trends. Increasing use of minimally invasive surgery and favorable reimbursement policies are additional factors fueling market growth. However, the preference for PCI surgeries and costs constraints could impede CABG acceptance in some areas.

Germany Coronary Artery Bypass Graft Market Insights:

The Germany Coronary Artery Bypass Graft benefits from good infrastructure for cardiac surgery, excellent networks of special hospitals, and highly trained cardiothoracic surgeons. An increase in cardiovascular diseases and the aging of the population contribute to growth. Good surgical practices, healthy financing of the health sector, and standardization have placed Germany among the top CABG markets in Europe.

Latin America Coronary Artery Bypass Graft Market Insights:

The Latin America Coronary Artery Bypass Graft Market is driven by the prevalence of heart diseases, improved access to cardiac surgery procedures, and the development of healthcare facilities. An increase in the number of patients opting for medical tourism in Brazil and Mexico, combined with low-cost treatment methods, drives market growth. Awareness levels and government health policies add to the momentum.

Middle East and Africa Coronary Artery Bypass Graft Market Insights:

The Middle East and Africa Coronary Artery Bypass Graft Market is growing due to advancements in healthcare infrastructure along with the increased number of sophisticated cardiac surgeries. Growing incidences of heart diseases, development of centers for cardiology, and governmental expenditure in nations such as UAE, Saudi Arabia, and South Africa are further contributing to the growth of the market.

Coronary Artery Bypass Graft Market Competitive Landscape:

Medtronic plc is a leading manufacturer of medical devices with a presence in the cardiovascular and cardiac surgery segment. It provides products for CABG surgery, such as heart-lung machines and surgical tools. The company maintains its market leadership by providing a diverse range of products, constantly innovating, and ensuring efficient distribution. The company focuses on developing advanced surgical techniques and establishing collaborations with hospitals to promote the use of its products. This has helped it maintain a dominant position in the CABG market.

• In September 2025, Medtronic plc expanded its cardiac surgery portfolio with advanced cardiopulmonary bypass and perfusion systems, enhancing efficiency and safety in CABG procedures and supporting high-volume cardiac surgery centers.

The Boston Scientific Corporation has established itself as a major player in the realm of cardiovascular devices by offering a wide array of products designed to manage coronary artery disease and incorporating additional technology that enhances the process of CABG surgery. It is able to maintain its market dominance due to its continued innovation and development of new products, which allow it to offer a diversified range of services within the area of cardiovascular care.

• In July 2025, Boston Scientific Corporation introduced enhancements in surgical support and cardiovascular intervention technologies, improving integration between interventional cardiology and surgical workflows, indirectly strengthening CABG procedure planning and outcomes.

Abbott Laboratories which is a well-known name in the healthcare space, has strong cardiac segment that sells devices supporting CABG procedures and surgeries. What makes this company so important is the array of complex products it offers, its global reach, and ongoing developments in cardiology. It largely emphasizes enhancing patient outcomes through advanced methods and cutting-edge technologies. Abbott Labs is a significant contributor to the CABG market though its close relationship with healthcare providers, which allows it through the provision of quality cardiac services.

• In June 2025, Abbott Laboratories advanced its cardiovascular surgical support technologies and imaging systems, improving intraoperative visualization and precision in complex coronary procedures, including CABG, thereby supporting better clinical outcomes and surgical decision-making.

Coronary Artery Bypass Graft Market Key Players:

Some of the Coronary Artery Bypass Graft Market Companies are: 

• Medtronic plc

• Boston Scientific Corporation

• Abbott Laboratories

• Terumo Corporation

• Edwards Lifesciences Corporation

• Getinge AB

• LivaNova PLC

• B. Braun Melsungen AG

• Johnson & Johnson (Ethicon)

• W. L. Gore & Associates, Inc.

• Cardinal Health, Inc.

• Cook Medical Incorporated

• Teleflex Incorporated

• Zimmer Biomet Holdings, Inc.

• MicroPort Scientific Corporation

• Artivion, Inc.

• CryoLife, Inc.

• Maquet Holding B.V. & Co. KG

• Sorin Group (LivaNova legacy)

• Stryker Corporation